Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Select Medical Holdings (SEM) Operating Expenses (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Operating Expenses for 8 consecutive years, with $45.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Expenses fell 94.86% to $45.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $154.4 million, a 96.86% decrease, with the full-year FY2025 number at $292.9 million, down 94.05% from a year prior.
  • Operating Expenses was $45.7 million for Q4 2025 at Select Medical Holdings, up from $40.0 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $1.6 billion in Q3 2024 to a low of -$5.5 million in Q4 2023.
  • A 5-year average of $988.2 million and a median of $1.4 billion in 2021 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: plummeted 116.46% in 2023, then skyrocketed 16134.93% in 2024.
  • Select Medical Holdings' Operating Expenses stood at $1.5 billion in 2021, then crashed by 97.75% to $33.7 million in 2022, then plummeted by 116.46% to -$5.5 million in 2023, then surged by 16134.93% to $888.2 million in 2024, then crashed by 94.86% to $45.7 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Operating Expenses are $45.7 million (Q4 2025), $40.0 million (Q3 2025), and $35.7 million (Q2 2025).